Company intelligence / Profile preview

Pathnostics

Irvine, California, United Statespathnostics.com ↗

Ownership: Private
Employees: ~175
Development stage: Preclinical

Overview

Pathnostics has completed eight clinical studies involving more than 73,000 subjects for their flagship Guidance® UTI platform. Key findings are published in fifteen peer-reviewed journals. Their diagnostic solutions provide results in less than one day, enabling more informed treatment decisions[1][2].

Therapeutic areas: OncologyInfectious Diseases
Modalities: Diagnostic testsmolecular testing
Industry: Molecular Diagnostics

Drug pipeline

3 assets

HCW9218

Pre-clinical

Indications: Pancreatic cancer, Solid tumors

2 more assets in the full pipeline.

Request access →

Partnerships

Water Street Healthcare Partners

Beyond the preview

Go deeper on Pathnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathnostics.

Explore the full profile